(Q38820110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

From melanocytes to melanomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

Author Correction: From melanocytes to melanomas

3 April 2020

corrigendum / erratum

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

A Hunter Shain

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

29 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

345-358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27125352%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc.2016.37

3 April 2020

exact match

0 references

cites work

The melanocyte lineage in development and disease

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Distinct sets of genetic alterations in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Improving melanoma classification by integrating genetic and morphologic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Determinants of BRAF mutations in primary melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

A landscape of driver mutations in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Highly recurrent TERT promoter mutations in human melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

TERT promoter mutations in familial and sporadic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mitotic activity in non-neoplastic melanocytes in vivo as determined by histochemical, autoradiographic, and electron microscope studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Human skin pigmentation: melanocytes modulate skin color in response to stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Central role of p53 in the suntan response and pathologic hyperpigmentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Photoprotection by melanin—a comparison of black and Caucasian skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mutations in GNA11 in uveal melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Frequency of Dermoscopic Nevus Subtypes by Age and Body Site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Number of melanocytic nevi as a major risk factor for malignant melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Site-specific melanocytic naevus counts as predictors of whole body naevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Cutaneous melanomas associated with nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Nevus-associated melanomas: clinicopathologic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

High frequency of BRAF mutations in nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

BRAF and NRAS mutations in melanoma and melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The Genetic Evolution of Melanoma from Precursor Lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Polyclonality of BRAF mutations in acquired melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Risk factors for lentigo maligna melanoma compared with superficial spreading melanoma: a case-control study in Australia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

MC1R and the response of melanocytes to ultraviolet radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

(Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

UVA, pheomelanin and the carcinogenesis of melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Prevalence of melanocytic nevi and freckles in young Israeli males. Correlation with melanoma incidence in Jewish migrants: demographic and host factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mutations induced by ultraviolet light

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

31 March 2020

UV signature mutations

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

BRAFE600-associated senescence-like cell cycle arrest of human naevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Cellular senescence: when bad things happen to good cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Cellular senescence in cancer and aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Growth and phenotypic characteristics of human nevus cells in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mitoses in conventional melanocytic nevi.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

One single erythemagenic UV irradiation is more effective in increasing the proliferative activity of melanocytes in melanocytic naevi compared with fractionally applied high doses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

IRF4 variants have age-specific effects on nevus count and predispose to melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Activating BRAF mutations in eruptive melanocytic naevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Grading of atypia in nevi: correlation with melanoma risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the world health organization melanoma programme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Clinical decision making based on histopathologic grading and margin status of dysplastic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

POT1 loss-of-function variants predispose to familial melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Dysplastic nevi. Markers for increased risk for melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

A natural history of melanomas and dysplastic nevi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Final version of 2009 AJCC melanoma staging and classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

A melanocyte--melanoma precursor niche in sweat glands of volar skin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mutations of the BRAF gene in benign and malignant melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The risk of progression of lentigo maligna to lentigo maligna melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ: Ki-67-labeling rate of junctional melanocytes and suprabasal cells may be a helpful clue to the diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Loss of p16 expression is associated with histological features of melanoma invasion

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRC.2016.37

31 March 2020

12 December 2020

Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61Kon an INK4a-Deficient Background

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The spectrum of SWI/SNF mutations, ubiquitous in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Absence of p53 gene mutations in cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Final trial report of sentinel-node biopsy versus nodal observation in melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Nodal nevi and cutaneous melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Benign nodal nevi frequently harbor the activating V600E BRAF mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Metastasizing cellular dermatofibroma. A report of two cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Benign metastasizing meningioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Clonal architectures and driver mutations in metastatic melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Whole genome sequencing of matched primary and metastatic acral melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Tumor self-seeding by circulating cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

The evolutionary history of lethal metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.37

Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal

31 March 2020

1 reference

12 December 2020

Diagnosis and Treatment of Early Melanoma

1 reference

12 December 2020

Anatomy, histology and immunohistochemistry of normal human skin

1 reference

12 December 2020

Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma

1 reference

12 December 2020

A cohort study of melanoma in patients with dysplastic nevi

1 reference

12 December 2020

Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression

1 reference

12 December 2020

Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors

1 reference

12 December 2020

Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization

1 reference

12 December 2020

Children with red hair have more freckles but fewer melanocytic nevi: results from a cohort study of 280 three-year-olds.

1 reference

12 December 2020

p53 gene mutation and expression in naevi and melanomas

1 reference

12 December 2020

Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression

1 reference

12 December 2020

Expression of mutant p53 in melanoma

1 reference

12 December 2020

Genomic Classification of Cutaneous Melanoma

1 reference

12 December 2020

Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent

1 reference

12 December 2020

"Benign," metastasizing adenomyoepithelioma of the breast: a report of 2 cases.

1 reference

12 December 2020

Frequency of acquired melanonevocytic nevi and their relationship to skin complexion in 939 schoolchildren

1 reference

12 December 2020

Development of invasive and growth factor-independent cell variants from primary human melanomas

1 reference

12 December 2020

Overexpression of p53 is a late event in the development of malignant melanoma

1 reference

12 December 2020

Benign metastasizing pleomorphic adenoma

1 reference

12 December 2020

Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi

1 reference

12 December 2020

Melanoma cell lines from different stages of progression and their biological and molecular analyses

1 reference

12 December 2020

Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy

1 reference

12 December 2020

The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects

1 reference

12 December 2020

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

1 reference

12 December 2020

The Genetic Evolution of Melanoma

1 reference

12 December 2020

Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry.

1 reference

12 December 2020

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

1 reference

12 December 2020